IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.
About IPO Scanner
IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.
Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.
Details of client bank account
For any query / feedback / clarifications, email at
[email protected].
Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.
© 2026 IPO Scanner. All rights reserved.
Want to stay updated?Subscribe to our newsletter
Incorporated in March 2015, Gaudium IVF and Women Health Limited have engaged in In Vitro Fertilization treatments throughout India and have expanded into several states utilizing a hub-and-spoke model. The company has more than thirty locations. These include seven hubs (centres) and twenty-eight spokes. The strategic alliance between the organization and Infertility Experts, referred to as Spokes, was forged in order to meet the mutual goal of spreading awareness about Assisted Reproductive Technology or ART and In Vitro Fertilization or IVF treatments.The patients come from various countries such as Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman. The company has hubs in Delhi, two Janakpuri and Kailash Colony; Mumbai; Khar West; Ludhiana; Srinagar; Patna; and Bangalore, covering all important locations across the subcontinent. This company offers a range of specialized fertility services: In Vitro Fertilization, Intracytoplasmic Sperm Injection, Intrauterine Insemination, and ovulation induction. Our treatments are specifically directed for a variety of infertility conditions in both males and females. We also provide comprehensive gynaecological care for PCOD/PCOS and endometriosis and high-risk pregnancy management for women with complex fertility history or health conditions. These facilities cover a wide scope of male infertility treatments, right from advanced sperm retrieval techniques.
Sotefin Bharat
Caliber Mining & Logistics
| Companies Name | Open - Close | Issue Size | Min. Qty | Issue Price | Apply |
|---|---|---|---|---|---|
Sotefin Bharat SME | 16th Jul 2026 - 20th Jul 2026 | 89.76 Cr | 600 Shares | ₹ 178.00 | |
Caliber Mining & Logistics Mainboard | 17th Jul 2026 - 21st Jul 2026 | 450.00 Cr | 35 Shares | ₹ 402.00 | |
Gulf Lloyds (India) SME | 20th Jul 2026 - 22nd Jul 2026 | 18.19 Cr | 1200 Shares | ₹ 100.00 |

Open Date
Feb 20, 2026
Close Date
Feb 24, 2026
Min Investment
₹14,931
Lot Size
189 Shares
Issue Size
₹165 Cr
Price Range
₹75 - ₹75
Listing Date
Feb 27, 2026
IPO Doc
RHP PDFRevenue Growth
Company Valuation
Earning Expansion
The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily.
The company will use approximately ₹50 crore for the establishment of new IVF Centers. The company will use ₹20 crore for repayment of certain outstanding loans availed by it. Part of the IPO proceeds will be used for general corporate purposes and issue expenses
Capital expenditure
55.5%
Repayment of borrowings
22.2%
General corporate purposes
22.3%
The company will use approximately ₹50 crore for the establishment of new IVF Centers.
The company will use ₹20 crore for repayment of certain outstanding loans availed by it.
Part of the IPO proceeds will be used for general corporate purposes and issue expenses
Times subscribed by category (bars capped at 10x for readability). Dashed line marks 1.0x (fully subscribed).
In Cr.
| Key Performance Indicator | 30-Sep-25 (In Cr.) | 31-Mar-25 (In Cr.) | 31-Mar-24 (In Cr.) | 31-Mar-23 (In Cr.) |
|---|---|---|---|---|
| Revenue | 49.75 | 70.96 | 48.15 | 44.26 |
| EBITDA | 18.95 | 28.63 | 19.27 | 20.07 |
| Expenses | ||||
| Profit After Tax | 12.51 | 19.13 | 10.32 | 13.53 |
| Assets | 106.62 | 88.51 | 51.01 | 36.63 |
| Net Worth | 58.85 | 46.30 | 26.99 | 22.73 |
| Reserves | 28.16 | 15.60 | 26.00 | 21.74 |
| Borrowing | 22.51 | 18.93 | 15.73 | 9.78 |
Dr. Manika Khanna
Dr. Peeyush Khanna
Vishad Khanna
99.99%
71.30%
Gaudium IVF & Women Health
B1/51, Janak Puri, B-1, New Delhi, New Delhi, 110058
Bigshare Services Pvt.Ltd.
Gaudium IVF offers a full spectrum of ART services, including IVF, ICSI, IMSI, IUI, TESA, cryopreservation and embryo transfer. The company treats complex conditions such as PCOS, endometriosis, azoospermia, and recurrent implantation failure. Advanced procedures like IMSI and TESA, which typically command higher realisations, support revenue per cycle and clinical differentiation.
Gaudium IVF employs next-generation embryology labs with INTEGRA Ti™ platforms for ICSI, advanced egg quality evaluation systems, and Samsung ultrasound machines for precise clinical monitoring. The company also offers highly technical USG-guided procedures, including HSG, transvaginal and transrectal scans, follicular monitoring, biopsies, and ovarian cyst aspiration. This technological depth allows for precise diagnosis and better decision-making in complex fertility cases.
Operations across seven IVF centres are supported by only five embryologists, each capable of handling up to 120 cycles per month. The loss of even one embryologist could materially disrupt operations, particularly as some centres rely on travelling embryologists. This concentration exposes the company to operational bottlenecks and scalability constraints.
As of September 30, 2025, the company disclosed contingent liabilities of 44.99 crore, which is 76% of the net worth of 58.85 crore. The bulk of these liabilities are disputing income tax demands amounting to more than 30.89 crore, out of which 20% (6.18 crore) has to be deposited in instalments even though appeals are pending. An unfavourable result may significantly impact liquidity and the overall strength of the balance sheet.